{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T21:57:51Z","timestamp":1791928671188,"version":"4.3.4"},"reference-count":35,"publisher":"Association for Research in Vision and Ophthalmology (ARVO)","issue":"6","license":[{"start":{"date-parts":[[2018,5,18]],"date-time":"2018-05-18T00:00:00Z","timestamp":1526601600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Invest. Ophthalmol. Vis. Sci."],"published-print":{"date-parts":[[2018,5,18]]},"DOI":"10.1167\/iovs.18-24096","type":"journal-article","created":{"date-parts":[[2018,5,30]],"date-time":"2018-05-30T15:36:33Z","timestamp":1527694593000},"page":"2470","source":"Crossref","is-referenced-by-count":31,"title":["RGC Neuroprotection Following Optic Nerve Trauma Mediated By Intranasal Delivery of Amnion Cell Secretome"],"prefix":"10.1167","volume":"59","author":[{"given":"Gabriela A.","family":"Grinblat","sequence":"first","affiliation":[{"name":"Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reas S.","family":"Khan","sequence":"additional","affiliation":[{"name":"Scheie Eye Institute and F.M. Kirby Center for Molecular Ophthalmology, University of Pennsylvania, Philadelphia, Pennsylvania, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kimberly","family":"Dine","sequence":"additional","affiliation":[{"name":"Scheie Eye Institute and F.M. Kirby Center for Molecular Ophthalmology, University of Pennsylvania, Philadelphia, Pennsylvania, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Howard","family":"Wessel","sequence":"additional","affiliation":[{"name":"Noveome Biotherapeutics, Inc., Pittsburgh, Pennsylvania, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Larry","family":"Brown","sequence":"additional","affiliation":[{"name":"Noveome Biotherapeutics, Inc., Pittsburgh, Pennsylvania, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth S.","family":"Shindler","sequence":"additional","affiliation":[{"name":"Scheie Eye Institute and F.M. Kirby Center for Molecular Ophthalmology, University of Pennsylvania, Philadelphia, Pennsylvania, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"27","reference":[{"key":"i1552-5783-59-6-2470-b01","doi-asserted-by":"crossref","unstructured":"Steinsapir KD, Goldberg, RA. Traumatic optic neuropathy: an evolving understanding. Am J Ophthalmol. 2011; 151: 928\u2013933.","DOI":"10.1016\/j.ajo.2011.02.007"},{"key":"i1552-5783-59-6-2470-b02","unstructured":"Cho RI, Savitsky E. Ocular trauma. In: Eastbridge B, Savitsky E, eds. Combat Casualty Care: Lessons Learned from OEF and OIF. Ft. Detrick, MD: Borden Institute (US) Government Printing Office; 2012: 299\u2013342."},{"key":"i1552-5783-59-6-2470-b03","doi-asserted-by":"crossref","unstructured":"Weichel ED, Colyer MH, Ludlow SE, et al. Combat ocular trauma visual outcome during operations Iraqi and Enduring Freedom. Ophthalmology. 2008; 115: 2235\u20132245.","DOI":"10.1016\/j.ophtha.2008.08.033"},{"key":"i1552-5783-59-6-2470-b04","doi-asserted-by":"crossref","unstructured":"Van Stavern GP, Biousse V, Lynn MJ, et al. Neuro-ophthalmic manifestations of head trauma. J Neuroophthalmol. 2001; 21: 112\u2013117.","DOI":"10.1097\/00041327-200106000-00012"},{"key":"i1552-5783-59-6-2470-b05","doi-asserted-by":"crossref","unstructured":"Levin LA, Beck RW, Joseph MP, et al. The treatment of traumatic optic neuropathy: the International Optic Nerve Trauma Study. Ophthalmology. 1999; 106: 1268\u20131277.","DOI":"10.1016\/S0161-6420(99)00707-1"},{"key":"i1552-5783-59-6-2470-b06","doi-asserted-by":"crossref","unstructured":"Banas R, Miller C, Guzik L, Zeevi A. Amnion-derived multipotent progenitor cells inhibit blood monocyte differentiation into mature dendritic cells. Cell Transplant. 2004; 23: 1111\u20131125.","DOI":"10.3727\/096368913X670165"},{"key":"i1552-5783-59-6-2470-b07","unstructured":"Steed DL, Trumpower C, Duffy D, et al. Amnion-derived cellular cytokine solution: a physiological combination of cytokines for wound healing. Eplasty. 2008; 8: 157\u2013165."},{"key":"i1552-5783-59-6-2470-b08","doi-asserted-by":"crossref","unstructured":"Khan RS, Dine K, Bauman B, et al. Intranasal delivery of a novel amnion cell secretome prevents neuronal damage and preserves function in a mouse multiple sclerosis model. Sci Rep. 2017; 7: 41768.","DOI":"10.1038\/srep41768"},{"key":"i1552-5783-59-6-2470-b09","doi-asserted-by":"crossref","unstructured":"Shindler KS, Ventura E, Rex TS, et al. SIRT1 activation confers neuroprotection in experimental optic neuritis. Invest Ophthalmol Vis Sci. 2007; 48: 3602\u20133609.","DOI":"10.1167\/iovs.07-0131"},{"key":"i1552-5783-59-6-2470-b10","doi-asserted-by":"crossref","unstructured":"Shindler KS, Ventura E, Dutt M, et al. Oral resveratrol reduces neuronal damage in a model of multiple sclerosis. J Neuroophthalmol. 2010; 30: 328\u201333.","DOI":"10.1097\/WNO.0b013e3181f7f833"},{"key":"i1552-5783-59-6-2470-b11","doi-asserted-by":"crossref","unstructured":"Fonseca-Kelly Z, Nassrallah M, Uribe J, et al. Resveratrol neuroprotection in a chronic mouse model of multiple sclerosis. Front Neurol. 2012; 3: 84.","DOI":"10.3389\/fneur.2012.00084"},{"key":"i1552-5783-59-6-2470-b12","doi-asserted-by":"crossref","unstructured":"Khan RS, Dine K, Das Sarma J, Shindler KS. SIRT1 activating compounds reduce oxidative stress mediated neuronal loss in viral induced CNS demyelinating disease. Acta Neuropathol Commun. 2014; 2: 3.","DOI":"10.1186\/2051-5960-2-3"},{"key":"i1552-5783-59-6-2470-b13","doi-asserted-by":"crossref","unstructured":"Zuo L, Khan RS, Lee V, et al. SIRT1 promotes RGC survival and delays loss of function following optic nerve crush. Invest Ophthalmol Vis Sci. 2013; 54: 5097\u20135102.","DOI":"10.1167\/iovs.13-12157"},{"key":"i1552-5783-59-6-2470-b14","unstructured":"Levkovitch-Verbin H, Harris-Cerruti C, Groner Y, et al. RGC death in mice after optic nerve crush injury: oxidative stress and neuroprotection. Invest Ophthalmol Vis Sci. 2000; 41: 4169\u20134174."},{"key":"i1552-5783-59-6-2470-b15","doi-asserted-by":"crossref","unstructured":"Al-Abdulla NA, Martin LJ. Apoptosis of retrogradely degenerating neurons occurs in association with the accumulation of perikaryal mitochondria and oxidative damage to the nucleus. Am J Pathol. 1998; 153: 447\u2013456.","DOI":"10.1016\/S0002-9440(10)65588-5"},{"key":"i1552-5783-59-6-2470-b16","doi-asserted-by":"crossref","unstructured":"Castagne V, Clarke PG. Axotomy-induced retinal ganglion cell death in development: its time course and its diminution by antioxidants. Proc R Soc Lond B Biol Sci. 1996; 263: 1193\u20131197.","DOI":"10.1098\/rspb.1996.0175"},{"key":"i1552-5783-59-6-2470-b17","doi-asserted-by":"crossref","unstructured":"Quinn T, Dutt M, Shindler KS. Optic neuritis and retinal ganglion cell loss in a chronic murine model of multiple sclerosis. Front Neurol. 2011; 2: 50.","DOI":"10.3389\/fneur.2011.00050"},{"key":"i1552-5783-59-6-2470-b18","doi-asserted-by":"crossref","unstructured":"Arnold AC. Evolving management of optic neuritis and multiple sclerosis. Am J Ophthalmol. 2005; 139: 1101\u20131108.","DOI":"10.1016\/j.ajo.2005.01.031"},{"key":"i1552-5783-59-6-2470-b19","doi-asserted-by":"crossref","unstructured":"Shindler KS, Ventura E, Dutt M, Rostami A. Inflammatory demyelination induces axonal injury and retinal ganglion cell apoptosis in experimental optic neuritis. Exp Eye Res. 2008; 87: 208\u2013213.","DOI":"10.1016\/j.exer.2008.05.017"},{"key":"i1552-5783-59-6-2470-b20","doi-asserted-by":"crossref","unstructured":"Meyer R, Weissert R, Diem R, et al. Acute neuronal apoptosis in a rat model of multiple sclerosis. J Neurosci. 2001; 21: 6214\u20136220.","DOI":"10.1523\/JNEUROSCI.21-16-06214.2001"},{"key":"i1552-5783-59-6-2470-b21","unstructured":"Potter NT, Bigazzi PE. Acute optic neuritis associated with immunization with the CNS myelin proteolipid protein. Invest Ophthalmol Vis Sci. 1992; 33: 1717\u20131722."},{"key":"i1552-5783-59-6-2470-b22","doi-asserted-by":"crossref","unstructured":"Payne WG, Wachtel TL, Smith CA, et al. Effect of amnion-derived cellular cytokine solution on healing of experimental partial-thickness burns. World J Surg. 2010; 34: 1663\u20131668.","DOI":"10.1007\/s00268-010-0420-9"},{"key":"i1552-5783-59-6-2470-b23","unstructured":"Franz MG, Payne WG, Xing L, et al. The use of amnion-derived cellular cytokine solution to improve healing in acute and chronic wound models. Eplasty. 2008; 8: e21."},{"key":"i1552-5783-59-6-2470-b24","doi-asserted-by":"crossref","unstructured":"Uberti MG, Lufkin AE, Pierpont YN, et al. Amnion-derived cellular cytokine solution promotes macrophage activity. Ann Plast Surg. 2001; 66: 575\u2013580.","DOI":"10.1097\/SAP.0b013e318212f1d0"},{"key":"i1552-5783-59-6-2470-b25","doi-asserted-by":"crossref","unstructured":"Uberti MG, Pierpont YN, Ko F, et al. Amnion-derived cellular cytokine solution (ACCS) promotes migration of keratinocytes and fibroblasts. Ann Plast Surg. 2010; 64: 632\u2013635.","DOI":"10.1097\/SAP.0b013e3181c39351"},{"key":"i1552-5783-59-6-2470-b26","doi-asserted-by":"crossref","unstructured":"Guan L, Suggs A, Galan E, et al. Topical application of ST266 reduces UV-induced skin damage. Clin Cosmet Investig Dermatol. 2017; 10: 459\u2013471.","DOI":"10.2147\/CCID.S147112"},{"key":"i1552-5783-59-6-2470-b27","doi-asserted-by":"crossref","unstructured":"Deng-Bryant Y, Readnower RD, Leung LY, et al. Treatment with amnion-derived cellular cytokine solution (ACCS) induces persistent motor improvement and ameliorates neuroinflammation in a rat model of penetrating ballistic-like brain injury. Restor Neurol Neurosci. 2015; 33: 189\u2013203.","DOI":"10.3233\/RNN-140455"},{"key":"i1552-5783-59-6-2470-b28","doi-asserted-by":"crossref","unstructured":"Deng-Bryant Y, Chen Z, van der Merwe C, et al. Long-term administration of amnion-derived cellular cytokine suspension promotes functional recovery in a model of penetrating ballistic-like brain injury. J Trauma Acute Care Surg. 2012; 73 (Suppl): S156\u2013S164.","DOI":"10.1097\/TA.0b013e3182625f5f"},{"key":"i1552-5783-59-6-2470-b29","doi-asserted-by":"crossref","unstructured":"Dhuria SV, Hanson LR, Frey WH II. Intranasal delivery to the central nervous system: mechanisms and experimental considerations. J Pharm Sci. 2010; 99: 1654\u20131673.","DOI":"10.1002\/jps.21924"},{"key":"i1552-5783-59-6-2470-b30","doi-asserted-by":"crossref","unstructured":"Thorne RG, Hanson LR, Ross TM, et al. Delivery of interferon-beta to the monkey nervous system following intranasal administration. Neuroscience. 2008; 152: 785\u2013797.","DOI":"10.1016\/j.neuroscience.2008.01.013"},{"key":"i1552-5783-59-6-2470-b31","doi-asserted-by":"crossref","unstructured":"Alcal\u00e1-Barraza SR, Lee MS, Hanson LR, et al. Intranasal delivery of neurotrophic factors BDNF, CNTF, EPO, and NT-4 to the CNS. J Drug Target. 2010; 18: 179\u2013190.","DOI":"10.3109\/10611860903318134"},{"key":"i1552-5783-59-6-2470-b32","doi-asserted-by":"crossref","unstructured":"Reger MA, Watson GS, Green PS, et al. Intranasal insulin administration dose-dependently modulates verbal memory and plasma amyloid-\u00df in memory-impaired older adults. J Alzheimers Dis. 2008; 13: 323\u2013331.","DOI":"10.3233\/JAD-2008-13309"},{"key":"i1552-5783-59-6-2470-b33","doi-asserted-by":"crossref","unstructured":"Craft S, Baker LD, Montine TJ, et al. Intranasal insulin therapy for Alzheimer disease and amnestic mild cognitive impairment. Arch Neurol. 2012; 69: 29\u201338.","DOI":"10.1001\/archneurol.2011.233"},{"key":"i1552-5783-59-6-2470-b34","doi-asserted-by":"crossref","unstructured":"Renner DB, Svitak AL, Gallus NJ, et al. Intranasal delivery of insulin via the olfactory nerve pathway. J Pharm Pharmacol. 2012; 64: 1709\u20131714.","DOI":"10.1111\/j.2042-7158.2012.01555.x"},{"key":"i1552-5783-59-6-2470-b35","doi-asserted-by":"crossref","unstructured":"Meyer CH, Krohne TU, Charbel Issa P, et al. Routes for drug delivery to the eye and retina: intravitreal injections. Dev Ophthalmol. 2016; 55: 63\u201370.","DOI":"10.1159\/000431143"}],"container-title":["Investigative Opthalmology & Visual Science"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/iovs.arvojournals.org\/article.aspx?articleid=2681860","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T21:30:53Z","timestamp":1791927053000},"score":1,"resource":{"primary":{"URL":"http:\/\/iovs.arvojournals.org\/article.aspx?doi=10.1167\/iovs.18-24096"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5,18]]},"references-count":35,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2018,5,1]]}},"URL":"https:\/\/doi.org\/10.1167\/iovs.18-24096","relation":{},"ISSN":["1552-5783"],"issn-type":[{"value":"1552-5783","type":"print"}],"subject":[],"published":{"date-parts":[[2018,5,18]]}}}